Medtronic Debt to Equity Ratio 2010-2025 | MDT

Current and historical debt to equity ratio values for Medtronic (MDT) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Medtronic debt/equity for the three months ending April 30, 2025 was 0.53.
Medtronic Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2025-04-30 $43.42B $48.26B 0.90
2025-01-31 $40.36B $49.62B 0.81
2024-10-31 $41.33B $48.72B 0.85
2024-07-31 $41.59B $48.16B 0.86
2024-04-30 $39.56B $50.42B 0.79
2024-01-31 $38.84B $52.00B 0.75
2023-10-31 $38.44B $51.65B 0.74
2023-07-31 $39.41B $51.37B 0.77
2023-04-30 $39.28B $51.67B 0.76
2023-01-31 $42.52B $51.62B 0.82
2022-10-31 $41.18B $52.06B 0.79
2022-07-31 $37.07B $52.84B 0.70
2022-04-30 $38.26B $52.72B 0.73
2022-01-31 $39.09B $52.71B 0.74
2021-10-31 $39.60B $52.16B 0.76
2021-07-31 $40.14B $51.66B 0.78
2021-04-30 $41.48B $51.60B 0.80
2021-01-31 $46.34B $50.93B 0.91
2020-10-31 $45.57B $50.32B 0.91
2020-07-31 $43.46B $50.44B 0.86
2020-04-30 $39.82B $50.87B 0.78
2020-01-31 $40.87B $51.95B 0.79
2019-10-31 $40.33B $50.72B 0.80
2019-07-31 $40.77B $50.50B 0.81
2019-04-30 $39.48B $50.21B 0.79
2019-01-31 $38.79B $49.94B 0.78
2018-10-31 $38.44B $49.71B 0.77
2018-07-31 $39.39B $50.33B 0.78
2018-04-30 $40.57B $50.82B 0.80
2018-01-31 $45.46B $50.34B 0.90
2017-10-31 $42.88B $51.58B 0.83
2017-07-31 $49.46B $50.79B 0.97
2017-04-30 $49.53B $50.33B 0.98
2017-01-31 $48.09B $49.49B 0.97
2016-10-31 $48.11B $50.29B 0.96
2016-07-31 $47.71B $50.89B 0.94
2016-04-30 $47.58B $52.06B 0.91
2016-01-31 $51.89B $50.82B 1.02
2015-10-31 $52.68B $52.27B 1.01
2015-07-31 $51.82B $52.81B 0.98
2015-04-30 $53.46B $53.23B 1.00
2015-01-31 $35.06B $20.17B 1.74
2014-10-31 $19.34B $19.44B 1.00
2014-07-31 $18.31B $19.25B 0.95
2014-04-30 $18.50B $19.44B 0.95
2014-01-31 $17.88B $19.35B 0.92
2013-10-31 $17.72B $18.74B 0.95
2013-07-31 $16.45B $18.52B 0.89
2013-04-30 $16.23B $18.67B 0.87
2013-01-31 $17.11B $17.84B 0.96
2012-10-31 $16.79B $17.18B 0.98
2012-07-31 $16.00B $17.26B 0.93
2012-04-30 $15.71B $17.11B 0.92
2012-01-31 $14.74B $17.17B 0.86
2011-10-31 $15.01B $16.74B 0.90
2011-07-31 $14.75B $16.34B 0.90
2011-04-30 $14.71B $15.97B 0.92
2011-01-31 $15.24B $15.36B 0.99
2010-10-31 $14.49B $14.83B 0.98
2010-07-31 $14.06B $14.60B 0.96
2010-04-30 $13.46B $14.63B 0.92
2010-01-31 $10.85B $14.32B 0.76
2009-10-31 $10.68B $13.61B 0.79
2009-07-31 $10.43B $13.14B 0.79
2009-04-30 $10.41B $13.18B 0.79
2009-01-31 $9.70B $13.06B 0.74
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $111.928B $33.537B
Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $235.957B 28.04
Boston Scientific (BSX) United States $147.560B 37.59
Stryker (SYK) United States $144.011B 30.10
EssilorLuxottica (ESLOY) France $128.708B 0.00
Lonza Group Ag (LZAGY) Switzerland $50.371B 0.00
Haleon (HLN) United Kingdom $48.904B 27.49
ResMed (RMD) United States $36.560B 27.72
Agilent Technologies (A) United States $33.258B 22.04
GE HealthCare Technologies (GEHC) United States $33.082B 15.84
Terumo (TRUMY) Japan $26.680B 34.37
Insulet (PODD) United States $21.438B 84.69
Koninklijke Philips (PHG) Netherlands $21.384B 15.43
Zimmer Biomet Holdings (ZBH) United States $18.060B 11.71
Baxter (BAX) United States $15.713B 11.81
Smith & Nephew SNATS (SNN) United Kingdom $12.872B 0.00
Demant (WILYY) Denmark $9.377B 0.00
Sunny Optical Technology (SNPTF) China $9.076B 0.00
Bio-Rad Laboratories (BIO) United States $6.175B 21.94
Lantheus Holdings (LNTH) United States $5.385B 13.58
Prestige Consumer Healthcare (PBH) United States $4.149B 18.47
Perrigo (PRGO) Ireland $3.664B 9.30
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.367B 15.31
ICU Medical (ICUI) United States $3.250B 24.18
Envista Holdings (NVST) United States $3.127B 26.73
GN Store Nord (GNNDY) Denmark $2.263B 19.32
QuidelOrtho (QDEL) United States $1.954B 13.59
LeMaitre Vascular (LMAT) United States $1.833B 41.46
AtriCure (ATRC) United States $1.565B 0.00
Acuren (TIC) United States $1.357B 0.00
Neogen (NEOG) United States $1.200B 15.67
AdaptHealth (AHCO) United States $1.161B 11.81
Green Thumb Industries (GTBIF) United States $1.048B 23.71
BioLife Solutions (BLFS) United States $1.046B 0.00
Phibro Animal Health (PAHC) United States $0.970B 12.80
Kestra Medical Technologies (KMTS) United States $0.904B 0.00
InMode (INMD) Israel $0.844B 8.55
Evolus (EOLS) United States $0.640B 0.00
CeriBell (CBLL) United States $0.624B 0.00
Owens & Minor (OMI) United States $0.602B 5.08
Maravai LifeSciences Holdings (MRVI) United States $0.542B 0.00
Capricor Therapeutics (CAPR) United States $0.538B 0.00
Curaleaf Holdings (CURLF) Canada $0.524B 0.00
Valneva SE (VALN) France $0.510B 0.00
Surmodics (SRDX) United States $0.417B 0.00
Tilray Brands (TLRY) Canada $0.407B 0.00
SNDL (SNDL) Canada $0.339B 0.00
VAREX IMAGING (VREX) United States $0.337B 12.53
SEMPERIT AG HLD (SEIGY) Austria $0.329B 0.00
Aurora Cannabis (ACB) Canada $0.329B 61.50
Canopy Growth (CGC) Canada $0.272B 0.00
Viemed Healthcare (VMD) United States $0.263B 22.50
Sanara MedTech (SMTI) United States $0.256B 0.00
Sanuwave Health (SNWV) United States $0.254B 0.00
ZimVie (ZIMV) United States $0.253B 11.63
Cerus (CERS) United States $0.252B 0.00
Cresco Labs (CRLBF) United States $0.245B 0.00
Quanterix (QTRX) United States $0.235B 0.00
OraSure Technologies (OSUR) United States $0.221B 0.00
Biote (BTMD) United States $0.207B 6.12
Brainsway (BWAY) Israel $0.206B 55.30
Omeros (OMER) United States $0.199B 0.00
TriSalus Life Sciences (TLSI) United States $0.196B 0.00
Organigram Global (OGI) Canada $0.187B 0.00
High Tide (HITI) Canada $0.185B 0.00
Utah Medical Products (UTMD) United States $0.179B 14.57
Verano Holdings (VRNOF) United States $0.174B 0.00
Exagen (XGN) United States $0.152B 0.00
Vireo Growth (VREOF) United States $0.140B 0.00
FitLife Brands (FTLF) United States $0.131B 15.33
Jin Medical (ZJYL) China $0.107B 0.00
MacroGenics (MGNX) United States $0.096B 0.00
Fonar (FONR) United States $0.090B 11.37
Veru (VERU) United States $0.090B 0.00
Quipt Home Medical (QIPT) United States $0.087B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Agape ATP (ATPC) $0.084B 0.00
TerrAscend (TSNDF) Canada $0.075B 0.00
Cytosorbents (CTSO) United States $0.068B 0.00
InterCure (INCR) Israel $0.068B 0.00
Apyx Medical (APYX) United States $0.066B 0.00
Zynex (ZYXI) United States $0.064B 0.00
ImmuCell (ICCC) United States $0.059B 0.00
Jushi Holdings (JUSHF) United States $0.054B 0.00
Modular Medical (MODD) United States $0.042B 0.00
Nephros (NEPH) United States $0.041B 48.64
United-Guardian (UG) United States $0.037B 13.19
Rockwell Medical (RMTI) United States $0.032B 0.00
Cellectar Biosciences (CLRB) United States $0.019B 0.00
Allurion Technologies (ALUR) United States $0.019B 0.00
Safety Shot (SHOT) United States $0.018B 0.00
Flora Growth (FLGC) United States $0.017B 0.00
INLIF (INLF) $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.011B 0.00
Meihua Medical Technologies (MHUA) China $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.008B 0.00
Senestech (SNES) United States $0.006B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00